Medical specialists from France tagged as investigators in clinical trials studying 21-hydroxylase Deficiency
Total 3 results
-
Maguelone Forest, MD, PhDSeen in:
- Lyon, University of Lyon
Trials:- NCT00617292 (Sub-Investigator)
Conditions: -
Michael David, MDSeen in:
- Lyon, University of Lyon
Trials:- NCT00617292 (Sub-Investigator)
Conditions: -
Pierre Chatelain, MDSeen in:
- Lyon, University of Lyon
Trials:- NCT00617292 (Principal Investigator)
Conditions:
Clinical Trials on 21-hydroxylase Deficiency
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Maria I. NewNational Center for Research Resources (NCRR); Office of Rare Diseases (ORD)Completed21-hydroxylase DeficiencyUnited States, Brazil
-
Johnson & Johnson Pharmaceutical Research & Development...Completed21-hydroxylase DeficiencyUnited States
-
Mayo ClinicRecruiting24-hydroxylase DeficiencyUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownAdrenal Hyperplasia, Congenital | 21-hydroxylase DeficiencyFrance
-
Vanderbilt UniversityApproved for marketing
-
University Hospital, Basel, SwitzerlandCompletedHydroxylase Deficiency
-
Vanderbilt University Medical CenterCompletedAutonomic Nervous System Diseases | Orthostatic Hypotension | Orthostatic Intolerance | Dopamine Beta-Hydroxylase DeficiencyUnited States
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)TerminatedAutonomic Nervous System Diseases | Orthostatic Hypotension | Orthostatic Intolerance | Dopamine Beta-Hydroxylase DeficiencyUnited States
-
Orphanetics Pharma Entwicklungs GmbHTerminatedPhenylalanine Hydroxylase Deficiencies